Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Life Science Instrumentations market in this environment.
In terms of revenue, this research report indicated that the global Life Science Instrumentations market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Life Science Instrumentations industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Agilent Technologies aims at producing XX K Units Life Science Instrumentations in 2020, with XX % production to take place in global market, Danaher Corporation accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Life Science Instrumentations Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Life Science Instrumentations Market
Agilent Technologies
Danaher Corporation
Perkinelmer
Shimadzu Corporation
Thermo Fisher Scientific
Becton, Dickinson and Company
Bio-Rad Laboratories
Bruker Corporation
F. Hoffmann-La Roche
Waters Corporation
...
Major Type of Life Science Instrumentations Covered in Prudent Markets report:
Hromatography
Flow Cytometer
Spectroscopy
Polymerase Chain Reaction
Microscopy
Application Segments Covered in Prudent Markets Market
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Hospitals
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Life Science Instrumentations Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Hromatography -Product Introduction and Major Manufacturers
1.1.2 Flow Cytometer -Product Introduction and Major Manufacturers
1.1.3 Spectroscopy -Product Introduction and Major Manufacturers
1.1.4 Polymerase Chain Reaction -Product Introduction and Major Manufacturers
1.1.5 Microscopy -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Life Science Instrumentations Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Life Science Instrumentations Market
3.1.1 Top Companies leading Life Science Instrumentations Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Life Science Instrumentations Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Life Science Instrumentations Market
3.2.1 Top Companies leading Life Science Instrumentations Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Life Science Instrumentations Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Life Science Instrumentations Market
3.3.1 Top Companies leading Life Science Instrumentations Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Life Science Instrumentations Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Life Science Instrumentations Market
3.4.1 Top Companies leading Life Science Instrumentations Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Life Science Instrumentations Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Life Science Instrumentations Market
3.5.1 Top Companies leading Life Science Instrumentations Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Life Science Instrumentations Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Life Science Instrumentations Market
3.6.1 Top Companies leading Life Science Instrumentations Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Life Science Instrumentations Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Life Science Instrumentations Market
3.7.1 Top Companies leading Life Science Instrumentations Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Life Science Instrumentations Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Life Science Instrumentations Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Life Science Instrumentations Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Life Science Instrumentations Sales and Growth Rate (2021-2027)
5.2 Global Life Science Instrumentations Sales Value and Growth Rate (2021-2027)
6 Life Science Instrumentations Competitive Analysis
6.1 Agilent Technologies
6.1.1 Agilent Technologies Company Profiles
6.1.2 Agilent Technologies Product Introduction
6.1.3 Agilent Technologies Life Science Instrumentations Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Danaher Corporation
6.2.1 Danaher Corporation Company Profiles
6.2.2 Danaher Corporation Product Introduction
6.2.3 Danaher Corporation Life Science Instrumentations Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Perkinelmer
6.3.1 Perkinelmer Company Profiles
6.3.2 Perkinelmer Product Introduction
6.3.3 Perkinelmer Life Science Instrumentations Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Shimadzu Corporation
6.4.1 Shimadzu Corporation Company Profiles
6.4.2 Shimadzu Corporation Product Introduction
6.4.3 Shimadzu Corporation Life Science Instrumentations Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Company Profiles
6.5.2 Thermo Fisher Scientific Product Introduction
6.5.3 Thermo Fisher Scientific Life Science Instrumentations Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Becton, Dickinson and Company
6.6.1 Becton, Dickinson and Company Company Profiles
6.6.2 Becton, Dickinson and Company Product Introduction
6.6.3 Becton, Dickinson and Company Life Science Instrumentations Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Bio-Rad Laboratories
6.7.1 Bio-Rad Laboratories Company Profiles
6.7.2 Bio-Rad Laboratories Product Introduction
6.7.3 Bio-Rad Laboratories Life Science Instrumentations Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Bruker Corporation
6.8.1 Bruker Corporation Company Profiles
6.8.2 Bruker Corporation Product Introduction
6.8.3 Bruker Corporation Life Science Instrumentations Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 F. Hoffmann-La Roche
6.9.1 F. Hoffmann-La Roche Company Profiles
6.9.2 F. Hoffmann-La Roche Product Introduction
6.9.3 F. Hoffmann-La Roche Life Science Instrumentations Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 Waters Corporation
6.10.1 Waters Corporation Company Profiles
6.10.2 Waters Corporation Product Introduction
6.10.3 Waters Corporation Life Science Instrumentations Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
7 Conclusion